Monoclonal Antibodies for Cancer
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
200
NCT05992337
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
Phase: N/A
Role: Collaborator
Start: Sep 1, 2021
Completion: Jan 31, 2025
Loading map...